ACCESSION: MSBNK-SMB_Measured-HSA001P0211010
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.14, Processed 2025.02.21, Annotated 2025.04.02, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyushu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 61
COMMENT: RAW_SPEC {'ProcedureBlank_3631': {'bp': 710111.0, 'sum': 1253931.0}, '7_posi_3954': {'bp': 478804.0, 'sum': 826095.0}, '7_posi_3716': {'bp': 498156.0, 'sum': 909763.0}, '8_posi_3652': {'bp': 514471.0, 'sum': 943162.0}, '19_posi_3714': {'bp': 537552.0, 'sum': 964835.0}, '19_posi_4037': {'bp': 547724.0, 'sum': 989339.0}, '16_posi_3926': {'bp': 555083.0, 'sum': 994379.0}, '11_posi_4039': {'bp': 557404.0, 'sum': 924465.0}, '4_posi_4081': {'bp': 566141.0, 'sum': 998509.0}, 'BLK02_3648': {'bp': 655197.0, 'sum': 1208730.0}, '9_posi_4041': {'bp': 526830.0, 'sum': 909649.0}, '17_posi_3935': {'bp': 541181.0, 'sum': 946555.0}, '12_posi_4190': {'bp': 554411.0, 'sum': 954402.0}, '18_posi_3716': {'bp': 572870.0, 'sum': 1062720.0}, 'ProcedureBlank_3757': {'bp': 600671.0, 'sum': 1127418.0}, '17_posi_4314': {'bp': 448451.0, 'sum': 750107.0}, '7_posi_4169': {'bp': 480343.0, 'sum': 815864.0}, '10_posi_3974': {'bp': 510126.0, 'sum': 874712.0}, '14_posi_4064': {'bp': 573424.0, 'sum': 962889.0}, '5_posi_3671': {'bp': 605272.0, 'sum': 1140748.0}, '1_posi_3757': {'bp': 606651.0, 'sum': 1114380.0}, '4_posi_3737': {'bp': 606672.0, 'sum': 1091480.0}, '8_posi_4189': {'bp': 524204.0, 'sum': 855837.0}, '19_posi_3821': {'bp': 560245.0, 'sum': 979620.0}, '13_posi_3695': {'bp': 601068.0, 'sum': 1151574.0}, '16_posi_4227': {'bp': 516504.0, 'sum': 869921.0}, '9_posi_3652': {'bp': 538727.0, 'sum': 978694.0}, '11_posi_3670': {'bp': 539172.0, 'sum': 1042537.0}, '9_posi_3736': {'bp': 541114.0, 'sum': 975561.0}, '14_posi_3629': {'bp': 578733.0, 'sum': 1059412.0}, '2_posi_3652': {'bp': 622310.0, 'sum': 1199667.0}, '3_posi_3672': {'bp': 627634.0, 'sum': 1158920.0}, '10_posi_3800': {'bp': 530445.0, 'sum': 962721.0}, '8_posi_3756': {'bp': 540222.0, 'sum': 986112.0}, '6_posi_4059': {'bp': 582412.0, 'sum': 945341.0}, '19_posi_4147': {'bp': 526015.0, 'sum': 858494.0}, '15_posi_3674': {'bp': 508010.0, 'sum': 916938.0}, '11_posi_4166': {'bp': 533281.0, 'sum': 924544.0}, '12_posi_3842': {'bp': 538541.0, 'sum': 944733.0}, '4_posi_3629': {'bp': 604728.0, 'sum': 1104882.0}, '1_posi_3653': {'bp': 598891.0, 'sum': 1146383.0}, '6_posi_3958': {'bp': 555834.0, 'sum': 953411.0}, '10_posi_3650': {'bp': 537930.0, 'sum': 997112.0}, '18_posi_4230': {'bp': 550857.0, 'sum': 947932.0}, '14_posi_3715': {'bp': 549001.0, 'sum': 1027499.0}, '4_posi_3981': {'bp': 543262.0, 'sum': 908180.0}, '17_posi_3673': {'bp': 536854.0, 'sum': 963139.0}, '10_posi_4084': {'bp': 514689.0, 'sum': 923861.0}, '16_posi_3674': {'bp': 510933.0, 'sum': 933313.0}, 'BLK02_4130': {'bp': 707378.0, 'sum': 1291834.0}, '5_posi_3779': {'bp': 635209.0, 'sum': 1130946.0}, 'BLK02_3903': {'bp': 617740.0, 'sum': 1121189.0}, '2_posi_4169': {'bp': 605423.0, 'sum': 997322.0}, '9_posi_3861': {'bp': 542692.0, 'sum': 958040.0}, 'BLK02_3756': {'bp': 652162.0, 'sum': 1221520.0}, '4_posi_3821': {'bp': 586106.0, 'sum': 1026555.0}, '6_posi_3652': {'bp': 572289.0, 'sum': 1035366.0}, '9_posi_3956': {'bp': 556103.0, 'sum': 919274.0}, '9_posi_4228': {'bp': 479362.0, 'sum': 765397.0}, '19_posi_3630': {'bp': 535984.0, 'sum': 985529.0}, '18_posi_3631': {'bp': 538773.0, 'sum': 1011886.0}}
COMMENT: RETENTION_TIME_STDEV 0.416
COMMENT: PRECURSOR_M/Z_RAW 211.155014
COMMENT: PRECURSOR_M/Z_STDEV 0.000065
COMMENT: PRECURSOR_IN_MS1 mz 211.155374; int 50.408; delta(ppm) 1.038055
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.195; C10H18N4O; [M+H]+; delta(ppm) 0.195101
COMMENT: PROPOSED_MF MS-FINDER 2.335; C10H18N4O; [M+H]+; delta(ppm) 0.191055
COMMENT: PROPOSED_MF SIRIUS5_Sirius 21.415; C10H18N4O; [M+H]+; delta(ppm) 0.191055
COMMENT: PROPOSED_MF SIRIUS5_Sirius 18.146; C12H20NO2; [M+H]+; delta(ppm) -6.167559
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C10H18N4O; [M+H]+; delta(ppm) 0.191055
COMMENT: PROPOSED_MF SIRIUS6_Sirius 35.584; C10H18N4O; [M+H]+; delta(ppm) 0.191055
COMMENT: PROPOSED_MF SIRIUS6_Sirius 34.510; C12H20NO2; [M+H]+; delta(ppm) -6.167559
COMMENT: PROPOSED_MF SIRIUS6_Sirius 29.552; C7H19FN4O2; [M+H]+; delta(ppm) -5.220354
COMMENT: PROPOSED_MF SIRIUS6_Sirius 6.802; C6H21N5OP; [M+H]+; delta(ppm) -1.272809
COMMENT: PROPOSED_MF SIRIUS6_Sirius 6.305; C8H16N7; [M+H]+; delta(ppm) 6.549750
COMMENT: PROPOSED_MF SIRIUS6_Sirius -4.271; C5H20N7S; [M+H]+; delta(ppm) -9.415356
COMMENT: PROPOSED_MF SIRIUS6_Sirius -6.974; C4H19N8P; [M+H]+; delta(ppm) 5.085867
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C10H18N4O; [M+H]+; delta(ppm) 0.191055
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.646; AELNGSYDNICUTH-UHFFFAOYSA-N; [M+H]+; 2-(4,5-dipropyl-1,3-oxazol-2-yl)guanidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.494; YKOUFZWBCNJRRJ-UHFFFAOYSA-N; [M+H]+; 3-ethyl-5-(1-piperazin-1-ylethyl)-1,2,4-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.000; KBIPXRKUZZOFHD-YUMQZZPRSA-N; [M+H]+; 3-[[(1S,2S)-2-aminocyclohexyl]methyl]-4-methyl-1H-1,2,4-triazol-5-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.746; ADQSRWKNIJOPSQ-UHFFFAOYSA-N; [M+H]+; 3-(1-propan-2-yltriazol-4-yl)piperidin-3-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.725; VFKFPZJOKUVRGP-UHFFFAOYSA-N; [M+H]+; 1-(3-morpholin-4-ylpropyl)pyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.665; IRRRCRKDFMWWNV-UHFFFAOYSA-N; [M+H]+; 2-(3-tert-butyl-1H-1,2,4-triazol-5-yl)morpholine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.562; PHGCLLXPEBPSET-UHFFFAOYSA-N; [M+H]+; 2-piperidin-4-yl-5-propan-2-yl-4H-1,2,4-triazol-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.465; DJYZSNKLDXAWIV-UHFFFAOYSA-N; [M+H]+; 5-(piperazin-1-ylmethyl)-3-propan-2-yl-1,2,4-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.444; PTFRHAMKQKTEMK-UHFFFAOYSA-N; [M+H]+; 3-(1,4-diazepan-1-ylmethyl)-5-ethyl-1,2,4-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.444; ZCDIOCPFJFEXGB-UHFFFAOYSA-N; [M+H]+; 1-[(5-ethyl-1,2,4-oxadiazol-3-yl)methyl]piperidin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.406; MYBOSVWEIVQZFM-UHFFFAOYSA-N; [M+H]+; 4-amino-5-methyl-N-(3-methylbutyl)-1H-pyrazole-3-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.220; IXGMLJQYJGATJH-UHFFFAOYSA-N; [M+H]+; N,4-diethyl-6-propan-2-yloxy-1,3,5-triazin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.170; CUXJQEPOWXJYHL-UHFFFAOYSA-N; [M+H]+; 4-ethoxy-6-ethyl-N-propan-2-yl-1,3,5-triazin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.169; DCOORNZXFCKEKZ-UHFFFAOYSA-N; [M+H]+; 4-butoxy-N-ethyl-6-methyl-1,3,5-triazin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.139; UMSQMUZGSTUAHL-UHFFFAOYSA-N; [M+H]+; N,N,4-triethyl-6-methoxy-1,3,5-triazin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.024; WGNULDMOVQJCAF-UHFFFAOYSA-N; [M+H]+; 4-[2-(diethylamino)ethoxy]pyrimidin-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -225.866; DCOORNZXFCKEKZ; [M+H]+; 4-Butoxy-N-ethyl-6-methyl-1,3,5-triazin-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -227.390; IXGMLJQYJGATJH; [M+H]+; N,4-diethyl-6-propan-2-yloxy-1,3,5-triazin-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -228.469; CUXJQEPOWXJYHL; [M+H]+; 4-ethoxy-6-ethyl-N-propan-2-yl-1,3,5-triazin-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -234.714; UMSQMUZGSTUAHL; [M+H]+; N,N,4-Triethyl-6-methoxy-1,3,5-triazin-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -293.071; MYBOSVWEIVQZFM; [M+H]+; 4-Amino-5-methyl-N-(3-methylbutyl)-1H-pyrazole-3-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -330.274; WGNULDMOVQJCAF; [M+H]+; 2-Amino-4-diethylaminoethoxypyrimidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -348.528; HVHHQHTXTGUMSR; [M+H]+; Amibuzin
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -417.864; AELNGSYDNICUTH; [M+H]+; Guanidine, (4,5-dipropyl-2-oxazolyl)-
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.020; DCOORNZXFCKEKZ; [M+H]+; 4-Butoxy-N-ethyl-6-methyl-1,3,5-triazin-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -229.581; MYBOSVWEIVQZFM; [M+H]+; 4-Amino-5-methyl-N-(3-methylbutyl)-1H-pyrazole-3-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -232.938; CUXJQEPOWXJYHL; [M+H]+; 1,3,5-Triazin-2-amine, 4-ethoxy-6-ethyl-N-(1-methylethyl)-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -243.040; HVHHQHTXTGUMSR; [M+H]+; 3-(Dimethylamino)-6-(1,1-dimethylethyl)-4-methyl-1,2,4-triazin-5(4H)-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -267.741; DCOORNZXFCKEKZ; [M+H]+; 1,3,5-Triazin-2-amine, 4-butoxy-N-ethyl-6-methyl-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -285.687; UMSQMUZGSTUAHL; [M+H]+; N,N,4-Triethyl-6-methoxy-1,3,5-triazin-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -286.507; IXGMLJQYJGATJH; [M+H]+; 1,3,5-Triazin-2-amine, N,4-diethyl-6-(1-methylethoxy)-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -303.699; AELNGSYDNICUTH; [M+H]+; Guanidine, (4,5-dipropyl-2-oxazolyl)-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -417.684; VFKFPZJOKUVRGP; [M+H]+; 1-(3-Morpholinopropyl)-1H-pyrazol-3-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -435.304; WGNULDMOVQJCAF; [M+H]+; Pyrimidine, 2-amino-4-(2-diethylaminoethoxy)-
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.035; MYBOSVWEIVQZFM; [M+H]+; 4-Amino-5-methyl-N-(3-methylbutyl)-1H-pyrazole-3-carboxamide
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C10H19N4O1; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1), SIRIUS5_Sirius(1), SIRIUS5_Zodiac(1);
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 7.748
MS$FOCUSED_ION: PRECURSOR_M/Z 211.155378
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-03di-0290000000-0ff87780cecde9958625
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  81.0697539 11.3417 81.070280 1.9489 2.99 0.2972 52 f{C6H9}/-1.51ppm,p-C4H10N4O1
  83.0854066 14.1076 83.085910 1.4323 3.38 0.4478 60 f{C6H11}/-1.45ppm,p-C4H8N4O1
  86.0598933 18.9686 86.060360 1.0690 4.14 0.2860 61 f{C4H8N1O1}/-1.71ppm,p-C6H11N3
  95.0854003 25.5380 95.085760 1.3882 5.75 0.4267 61 f{C7H11}/-1.33ppm,p-C3H8N4O1
  97.1010802 12.2799 97.101425 1.5654 3.32 0.3802 56 f{C7H13}/-0.99ppm,p-C3H6N4O1
  109.1010533 20.9622 109.101290 1.3565 4.99 0.4244 61 f{C8H13}/-1.13ppm,p-C2H6N4O1
  111.0915844 11.8904 111.091800 1.8813 3.22 0.1667 53 f{C6H11N2}/-0.81ppm,p-C4H8N2O1
  125.0946889 21.0497 125.094730 1.3909 4.54 0.2214 61 f{C6H11N3}/-0.48ppm,p-C4H8N1O1
  126.1026332 46.7345 126.102660 1.2767 5.44 0.4942 61 f{C6H12N3}/0.47ppm,p-C4H7N1O1
  127.0866274 49.6423 127.086640 1.0229 7.87 0.2468 61 f{C6H11N2O1}/0.30ppm,p-C4H8N2
  133.1010590 11.9022 133.100980 2.3366 2.95 0.2451 54 f{C10H13}/-0.89ppm,p-H6N4O1
  140.0816957 9.6615 140.081600 2.8769 2.39 0.1411 45 f{C6H10N3O1}/-1.02ppm,p-C4H9N1
  141.1020164 15.3914 141.101920 2.0553 3.93 0.2410 60 f{C7H13N2O1}/-1.58ppm,p-C3H6N2
  143.0813677 15.9912 143.081270 1.3349 3.78 0.3464 61 ?
  151.1480229 10.8577 151.147920 2.4810 2.40 0.3459 45 ?
  175.1481083 51.3752 175.147990 1.3018 7.62 0.6473 61 ?
  193.1441996 45.1057 193.144070 1.9364 6.03 0.6756 61 f{C10H17N4}/-2.97ppm,p-H2O1
  193.1592196 27.6980 193.159090 2.3711 4.81 0.3768 58 ?
  211.0979208 92.9201 211.097780 0.7532 30.77 0.3475 60 ?
  211.1195108 71.1713 211.119370 0.7910 10.90 0.4724 61 ?
  211.1551208 999.0000 211.154980 0.3552 0.00 1.0000 61 f{C10H19N4O1}/-1.03ppm,p
  211.1722608 61.5923 211.172120 1.6953 9.51 0.6832 61 ?
PK$NUM_PEAK: 22
PK$PEAK: m/z int. rel.int.
  81.069754 11.34 11
  83.085407 14.11 14
  86.059893 18.97 18
  95.085400 25.54 25
  97.101080 12.28 12
  109.101053 20.96 20
  111.091584 11.89 11
  125.094689 21.05 21
  126.102633 46.73 46
  127.086627 49.64 49
  133.101059 11.90 11
  140.081696 9.66 9
  141.102016 15.39 15
  143.081368 15.99 15
  151.148023 10.86 10
  175.148108 51.38 51
  193.144200 45.11 45
  193.159220 27.70 27
  211.097921 92.92 92
  211.119511 71.17 71
  211.155121 999.00 999
  211.172261 61.59 61
//
